Similar articles for PMID: 33622873

Year	Number of Results
1994	4
1995	1
1996	3
1997	4
1998	2
1999	9
2000	7
2001	8
2002	6
2003	3
2004	1
2005	1
2006	7
2007	3
2009	2
2010	2
2011	2
2012	2
2013	4
2014	3
2015	3
2016	3
2017	6
2018	5
2019	3
2021	1
2022	2
2023	1
2024	0

1

Gene Expression Profile of Vascular Endothelial Growth Factors (VEGFs) and Platelet-derived Growth Factors (PDGFs) in the Normal Cornea.

Dan Cosnita AR, Raica M, Sava MP, Cimpean AM. Dan Cosnita AR, et al. In Vivo. 2021 Mar-Apr;35(2):805-813. doi: 10.21873/invivo.12321. In Vivo. 2021. PMID: 33622873 Free PMC article.

2

The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.

Dell S, Peters S, Müther P, Kociok N, Joussen AM. Dell S, et al. Invest Ophthalmol Vis Sci. 2006 May;47(5):1928-37. doi: 10.1167/iovs.05-1071. Invest Ophthalmol Vis Sci. 2006. PMID: 16639000

3

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.

Ambati BK, Patterson E, Jani P, Jenkins C, Higgins E, Singh N, Suthar T, Vira N, Smith K, Caldwell R. Ambati BK, et al. Br J Ophthalmol. 2007 Apr;91(4):505-8. doi: 10.1136/bjo.2006.107417. Epub 2006 Dec 6. Br J Ophthalmol. 2007. PMID: 17151056 Free PMC article.

4

Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.

Cao R, Bråkenhielm E, Li X, Pietras K, Widenfalk J, Ostman A, Eriksson U, Cao Y. Cao R, et al. FASEB J. 2002 Oct;16(12):1575-83. doi: 10.1096/fj.02-0319com. FASEB J. 2002. PMID: 12374780

5

Rapid ocular angiogenic control via naked DNA delivery to cornea.

Stechschulte SU, Joussen AM, von Recum HA, Poulaki V, Moromizato Y, Yuan J, D'Amato RJ, Kuo C, Adamis AP. Stechschulte SU, et al. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1975-9. Invest Ophthalmol Vis Sci. 2001. PMID: 11481260

6

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Philipp W, Speicher L, Humpel C. Philipp W, et al. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2514-22. Invest Ophthalmol Vis Sci. 2000. PMID: 10937562

7

Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.

Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE. Lai CM, et al. Exp Eye Res. 2002 Dec;75(6):625-34. doi: 10.1006/exer.2002.2075. Exp Eye Res. 2002. PMID: 12470964

8

Vascular endothelial growth factor and its receptors.

Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ. Neufeld G, et al. Prog Growth Factor Res. 1994;5(1):89-97. doi: 10.1016/0955-2235(94)90019-1. Prog Growth Factor Res. 1994. PMID: 7515293 Review.

9

Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.

Darden J, Payne LB, Zhao H, Chappell JC. Darden J, et al. Angiogenesis. 2019 Feb;22(1):167-183. doi: 10.1007/s10456-018-9648-z. Epub 2018 Sep 20. Angiogenesis. 2019. PMID: 30238211 Free PMC article.

10

Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.

Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY. Guo P, et al. Am J Pathol. 2003 Apr;162(4):1083-93. doi: 10.1016/S0002-9440(10)63905-3. Am J Pathol. 2003. PMID: 12651601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year